UK's new antibody treatment against Covid may work against Omicron

The UK's medicines regulator on Thursday approved a new antibody treatment against COVID-19, which it believes will also be effective against new variants such as Omicron. IMAGE: A nurse prepares......

Pressure on UK to review Covid vax rules for Indians

The UK government is under increasing pressure on Monday to review its COVID-19 vaccine protocol in place for travellers from India, after its updated rules effective from next month failed to......

Novovax Covid vaccine likely to get nod in India ahead of US

Adar Poonawalla said he was hopeful that Covovax, the Novavax vaccine made by SII, will be launched around October this year for adults and for children by the first quarter of next year, depending......

UK eases travel restrictions for India

The United Kingdom on Sunday eased travel restrictions for India by moving the country from its "red" to "amber" list, which means fully vaccinated Indian passengers will no longer be subjected to......

Markets end lower amid weak global cues

IT majors Infosys and TCS were the top losers while capital goods shares BHEL and L&T ended firm on robust core sector growth. Despite a marginal recovery in late trades benchmark share indices......

Wockhardt to recall some drugs made in India

Pharmaceuticals major Wockhardt is recalling select drugs in the US, manufactured at its two units at Chikalthana and Waluj in Maharashtra, which were under import restrictions from the USFDA.......

Pharma in 2014: Deals worth billions and fines worth millions

Even as private firms were busy stitching merger and partnership deals, the government also remained active during the year working on a separate policy to promote and strengthen domestic......

Wockhardt's Shendra unit set for key US test

The Food and Drugs Administration, US regulator, is likely to visit Wockhardt's factory in Shendra (Aurangabad district of Maharashtra) for an inspection this month, it is learnt. If the company......